Department of Neurology, Seoul National University Hospital, Seoul, Korea.
Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Korea.
J Korean Med Sci. 2020 Jun 1;35(21):e135. doi: 10.3346/jkms.2020.35.e135.
Neurocritical care by dedicated neurointensivists may improve outcomes of critically ill patients with severe brain injury. In this study, we aimed to validate whether neurointensive care could improve the outcome in patients with critically ill acute ischemic stroke using the linked big dataset on stroke in Korea.
We included 1,405 acute ischemic stroke patients with mechanical ventilator support in the intensive care unit after an index stroke. Patients were retrieved from linking the Clinical Research Center for Stroke Registry and the Health Insurance Review and Assessment Service data from the period between January 2007 and December 2014. The outcomes were mortality at discharge and at 3 months after an index stroke. The main outcomes were compared between the centers with and without dedicated neurointensivists.
Among the included patients, 303 (21.6%) were admitted to the centers with dedicated neurointensivists. The patients treated by dedicated neurointensivists had significantly lower in-hospital mortality (18.3% vs. 26.8%, = 0.002) as well as lower mortality at 3-month (38.0% vs. 49.1%, < 0.001) than those who were treated without neurointensivists. After adjusting for confounders, a treatment without neurointensivists was independently associated with higher in-hospital mortality (odds ratio [OR], 1.59; 95% confidence intervals [CIs], 1.13-2.25; = 0.008) and 3-month mortality (OR, 1.48; 95% CIs, 1.12-1.95; = 0.005).
Treatment by dedicated neurointensivists is associated with lower in-hospital and 3-month mortality using the linked big datasets for stroke in Korea. This finding stresses the importance of neurointensivists in treating patients with severe ischemic stroke.
由神经重症医师进行神经重症监护可能会改善患有严重脑损伤的重症患者的预后。在这项研究中,我们旨在使用韩国卒中大型数据集验证神经重症监护是否可以改善急性缺血性卒中重症患者的预后。
我们纳入了 2007 年 1 月至 2014 年 12 月期间在卒中登记处临床研究中心和健康保险审查与评估服务数据中检索到的 1405 例接受机械通气支持的重症监护病房急性缺血性卒中患者。将患者分为有和无神经重症监护病房两组。主要结局是出院时和卒中后 3 个月的死亡率。
在纳入的患者中,有 303 例(21.6%)入住了有神经重症监护病房的中心。与未接受神经重症监护治疗的患者相比,接受神经重症监护治疗的患者院内死亡率(18.3% vs. 26.8%, = 0.002)和 3 个月死亡率(38.0% vs. 49.1%, < 0.001)均显著降低。在校正混杂因素后,未接受神经重症监护治疗与较高的院内死亡率(优势比[OR],1.59;95%置信区间[CI],1.13-2.25; = 0.008)和 3 个月死亡率(OR,1.48;95% CI,1.12-1.95; = 0.005)独立相关。
使用韩国卒中大型数据集,与未接受神经重症监护治疗的患者相比,接受神经重症监护治疗与较低的院内和 3 个月死亡率相关。这一发现强调了神经重症医师在治疗严重缺血性卒中患者中的重要性。